Korean Government to reduce biopharmaceutical approval period to half

20 May 2019 - The Korean government plans to reduce by half the current one and a half years of ...

Read more →

Helping Canadians get faster access to the prescription drugs they need to live healthier lives

13 May 2019 - Government of Canada consults on new approach to fast-track the review of treatments for serious, rare ...

Read more →

Speed up cancer funding, ALP told

11 May 2019 - The head of Australian drug company Specialised Therapeutics, Carlo Montagner, has warned that Bill Shorten’s cancer ...

Read more →

Canadians will wait longer for new medicines if Health Canada gets its way

23 April 2019 - The intention is to lower prices; the net result will likely be longer wait times before new ...

Read more →

Additional embargo period following revised CDEC recommendations

17 April 2019 - Effective immediately, CADTH has revised its procedures for the CADTH Common Drug Review to permit an ...

Read more →

PHARMAC's early access scheme needs work - Prime Minister Jacinda Ardern

16 April 2019 - Prime Minister Jacinda Ardern admits work needs to be done on PHARMAC's early access scheme, but ...

Read more →

Daiichi Sankyo provides update on ongoing FDA review for quizartinib for treatment of patients with relapsed/refractory FLT3-ITD AML

4 April 2019 - Daiichi Sankyo today announced that the U.S. FDA has extended the review period for the new ...

Read more →

Drug companies call out PHARMAC for lack of transparency and timeliness

3 April 2019 - Two of the world's largest pharmaceutical companies say New Zealand is lagging behind other countries when ...

Read more →

Whanganui District Health Board says small number of patients affects cancer treatment wait time results

28 March 2019 - Whanganui District Health Board failed to meet the national faster cancer treatment target in January. ...

Read more →

Cancer Society critical of PHARMAC saying they 'lack accountability, lack transparency, are slow'

26 March 2019 - PHARMAC "lack accountability, lack transparency, are slow", in delivering pharmaceutical drugs to New Zealanders who need ...

Read more →

Biosimilar approval and adoption in the U.S. needs to be expedited

20 March 2019 - Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999 and 2010. ...

Read more →

The shadow of Brexit on speed of access

20 March 2019 - No-one can miss the ongoing saga that is the UK’s exit from the European Union.  ...

Read more →

Karyopharm announces FDA extension of review period for selinexor new drug application

14 March 2019 - PDUFA action date extended by three months to July 6, 2019. ...

Read more →

One in four cancer patients wait two months for treatment, as NHS performance hits record low

14 March 2019 - The number of cancer sufferers waiting at least two months for treatment after an urgent referral ...

Read more →

Bavarian Nordic announces FDA delay in the review of the biologics license application for MVA-BN smallpox vaccine

11 March 2019 - Bavarian Nordic today announced that it has received information from the U.S. FDA that the review ...

Read more →